CUAMC
EDIT icon

China Universal Asset Management Company’s Editas Medicine EDIT Stock Holding History

China Universal Asset Management Company’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144K Buy
44,424
+27,101
+156% +$79.2K 0.01% 383
2026
Q1 		$42.8K Buy
17,323
+1,416
+9% +$3K ﹤0.01% 466
2025
Q4 		$32.6K Buy
15,907
+145
+0.9% +$419 ﹤0.01% 475
2025
Q3 		$54.7K Sell
15,762
-1,051
-6% -$2.93K ﹤0.01% 425
2025
Q2 		$37K Buy
16,813
+255
+2% +$417 ﹤0.01% 436
2025
Q1 		$19.2K Sell
16,558
-945
-5% -$1.39K ﹤0.01% 457
2024
Q4 		$22.2K Buy
17,503
+1,640
+10% +$4.18K ﹤0.01% 482
2024
Q3 		$54.1K Buy
15,863
+6,202
+64% +$27K 0.01% 383
2024
Q2 		$45.1K Sell
9,661
-6,052
-39% -$34.1K 0.01% 365
2024
Q1 		$117K Buy
15,713
+6,263
+66% +$52K 0.01% 357
2023
Q4 		$95.7K Buy
9,450
+7,355
+351% +$64.6K 0.02% 285
2023
Q3 		$16.3K Buy
2,095
+1,190
+131% +$10.2K ﹤0.01% 312
2023
Q2 		$7.45K Sell
905
-30
-3% -$261 ﹤0.01% 337
2023
Q1 		$6.78K Buy
935
+237
+34% +$2.11K ﹤0.01% 339
2022
Q4 		$6.19K Buy
698
+54
+8% +$593 ﹤0.01% 272
2022
Q3 		$8K Buy
+644
New +$10K ﹤0.01% 223

Other funds holding EDIT

TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

China Universal Asset Management Company's EDIT Position: Q2 2026 in Review

China Universal Asset Management Company increased its Editas Medicine (EDIT) stake by 156% in Q2 2026, buying an estimated $79.2K and bringing the position to 44,424 shares worth $144K. The position accounts for 0.01% of the portfolio, ranked #383.

China Universal Asset Management Company first reported a position in EDIT in Q3 2022 and has held it in 16 quarters since. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • China Universal Asset Management Company held 44,424 shares of Editas Medicine worth $144K as of Q2 2026.
  • China Universal Asset Management Company bought 27,101 Editas Medicine shares in Q2 2026, an estimated $79.2K.
  • Editas Medicine made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #383 holding.
  • China Universal Asset Management Company first reported a position in Editas Medicine in Q3 2022 and has held it in 16 quarters since.
  • 215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.